The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
Open accessAbstract
PresentationT he patient is a 63-year-old man with a history of well- controlled hypertension who is diagnosed with diffuse large B-cell lymphoma and treated with a doxorubicincontaining chemotherapy regimen.During therapy, he is continued on hydrochlorothiazide for his hypertension.Three months later, he complains of dyspnea on exertion and mild lower extremity edema.A transthoracic echocardiogram reveals a moderately reduced left ventricular ejection fraction (LVEF), which is new compared with a study performed before he underwent chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Motzer, R. J., Hutson, T. E., Tomczak, P., Michaelson, M. D., Bukowski, R. M., Rixe, O., Oudard, S., Negrier, S., Szczylik, C., Kim, S. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065044 · Cited by 5,775
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Pericytes regulate the blood–brain barrier
Armulik, A., Genové, G., Mäe, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., He, L., Norlin, J., Lindblom, P., Strittmatter, K., et al. (2010) · Nature · doi:10.1038/nature09522 · Cited by 2,843 · cited 1×
“Although it is unclear exactly how pericytes support coronary microvascular function, pericytes are known to regulate the blood–brain barrier and loss of pericytes leads to increased vascular permeability.(113)”
BackgroundAdjuvant Trastuzumab in HER2-Positive Breast Cancer
Slamon, D., Eiermann, W., Robert, N., Pienkowski, T., Martin, M., Press, M., Mackey, J., Glaspy, J., Chan, A., Pawlicki, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa0910383 · Cited by 2,775
Trastuzumab — Mechanism of Action and Use in Clinical Practice
Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,585
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226 · cited 1×
“PDGFR inhibition impairs the growth and survival of pericytes, a type of cell that is closely associated with the microvasculature of some tissues and supports microvascular function.(111,112) Although it is unclear exactly how pericytes support coronary microvascular function, pericytes are known to regulate the bloo…”
BackgroundIdentification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
Hellström, M., Kalén, M., Lindahl, P., Abramsson, A., & Betsholtz, C. (1999) · Development · doi:10.1242/dev.126.14.3047 · Cited by 1,700
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,432
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijns, H. J., & Moens, A. L. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.006 · Cited by 1,414
Anthracycline-Induced Cardiomyopathy
Cardinale, D., Colombo, A., Lamantia, G., Colombo, N., Civelli, M., De Giacomi, G., Rubino, M., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.095 · Cited by 1,105
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Chu, T. F., Rupnick, M. A., Kerkela, R., Dallabrida, S. M., Zurakowski, D., Nguyen, L., Woulfe, K., Pravda, E., Cassiola, F., Desai, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61865-0 · Cited by 1,083
Ratain, M. J., Eisen, T., Stadler, W. M., Flaherty, K. T., Kaye, S. B., Rosner, G. L., Gore, M., Desai, A. A., Patnaik, A., Xiong, H. Q., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6723 · Cited by 1,032
Fryer, L. G. D., Parbu-Patel, A., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202489200 · Cited by 1,029
Cardinale, D., Colombo, A., Sandri, M. T., Lamantia, G., Colombo, N., Civelli, M., Martinelli, G., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2006) · Circulation · doi:10.1161/circulationaha.106.635144 · Cited by 1,026
Shiojima, I. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24682 · Cited by 939
ErbB2 is essential in the prevention of dilated cardiomyopathy
Crone, S. A., Zhao, Y.-Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K. L., Chen, J., Kahn, R., Condorelli, G., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-459 · Cited by 903
Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition
Force, T., Krause, D. S., & Van Etten, R. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2106 · Cited by 801
Šimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 769
Ewer, M. S., Vooletich, M. T., Durand, J.-B., Woods, M. L., Davis, J. R., Valero, V., & Lenihan, D. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.13.300 · Cited by 726
Self-citationProtective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 713
Bosch, X., Rovira, M., Sitges, M., Domènech, A., Ortiz-Pérez, J. T., de Caralt, T. M., Morales-Ruiz, M., Perea, R. J., Monzó, M., & Esteve, J. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.072 · Cited by 632
Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Schmidinger, M., Zielinski, C. C., Vogl, U. M., Bojic, A., Bojic, M., Schukro, C., Ruhsam, M., Hejna, M., & Schmidinger, H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.6331 · Cited by 615
Lyu, Y. L., Kerrigan, J. E., Lin, C.-P., Azarova, A. M., Tsai, Y.-C., Ban, Y., & Liu, L. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1649 · Cited by 612
Bowles, E. J. A., Wellman, R., Feigelson, H. S., Onitilo, A. A., Freedman, A. N., Delate, T., Allen, L. A., Nekhlyudov, L., Goddard, K. A. B., Davis, R. L., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs317 · Cited by 566
Cardioprotective interventions for cancer patients receiving anthracyclines
van Dalen, E. C., Caron, H. N., Dickinson, H. O., & Kremer, L. C. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003917.pub4 · Cited by 553
Fazel, S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27019 · Cited by 517
Targeting Tyrosine Kinases in Cancer: The Second Wave
Baselga, J. (2006) · Science · doi:10.1126/science.1125951 · Cited by 478
Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy
Özcelik, C., Erdmann, B., Pilz, B., Wettschureck, N., Britsch, S., Hübner, N., Chien, K. R., Birchmeier, C., & Garratt, A. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122249299 · Cited by 473
Early Breast Cancer Therapy and Cardiovascular Injury
Jones, L. W., Haykowsky, M. J., Swartz, J. J., Douglas, P. S., & Mackey, J. R. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.037 · Cited by 447
Gundewar, S., Calvert, J. W., Jha, S., Toedt-Pingel, I., Yong Ji, S., Nunez, D., Ramachandran, A., Anaya-Cisneros, M., Tian, R., & Lefer, D. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.190918 · Cited by 423
Eschenhagen, T., Force, T., Ewer, M. S., de Keulenaer, G. W., Suter, T. M., Anker, S. D., Avkiran, M., de Azambuja, E., Balligand, J.-L., Brutsaert, D. L., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq213 · Cited by 413
Maitland, M. L., Bakris, G. L., Black, H. R., Chen, H. X., Durand, J.-B., Elliott, W. J., Ivy, S. P., Leier, C. V., Lindenfeld, J., Liu, G., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq091 · Cited by 410
Bovelli, D., Plataniotis, G., & Roila, F. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq200 · Cited by 401
Wu, S., Chen, J. J., Kudelka, A., Lu, J., & Zhu, X. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70003-2 · Cited by 386
Viani, G. A., Afonso, S. L., Stefano, E. J., De Fendi, L. I., & Soares, F. V. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-153 · Cited by 381
Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer Therapeutics
Chen, M. H., Kerkelä, R., & Force, T. (2008) · Circulation · doi:10.1161/circulationaha.108.776831 · Cited by 379
Arany, Z., Novikov, M., Chin, S., Ma, Y., Rosenzweig, A., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603615103 · Cited by 374
Lebrin, F., Srun, S., Raymond, K., Martin, S., van den Brink, S., Freitas, C., Bréant, C., Mathivet, T., Larrivée, B., Thomas, J.-L., et al. (2010) · Nature Medicine · doi:10.1038/nm.2131 · Cited by 369
Force, T., & Kolaja, K. L. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3252 · Cited by 363
Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer
Chen, J., Long, J. B., Hurria, A., Owusu, C., Steingart, R. M., & Gross, C. P. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.068 · Cited by 352
Management of hypertension in angiogenesis inhibitor-treated patients
Izzedine, H., Ederhy, S., Goldwasser, F., Soria, J. C., Milano, G., Cohen, A., Khayat, D., & Spano, J. P. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn713 · Cited by 347
VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management
Izzedine, H., Massard, C., Spano, J. P., Goldwasser, F., Khayat, D., & Soria, J. C. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.11.001 · Cited by 332
(2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.003 · Cited by 331
Lai, L., Leone, T. C., Zechner, C., Schaeffer, P. J., Kelly, S. M., Flanagan, D. P., Medeiros, D. M., Kovacs, A., & Kelly, D. P. (2008) · Genes & Development · doi:10.1101/gad.1661708 · Cited by 326
Seicean, S., Seicean, A., Plana, J. C., Budd, G. T., & Marwick, T. H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.067 · Cited by 326
Izumiya, Y., Shiojima, I., Sato, K., Sawyer, D. B., Colucci, W. S., & Walsh, K. (2006) · Hypertension · doi:10.1161/01.hyp.0000215207.54689.31 · Cited by 326
Kaya, M. G., Ozkan, M., Gunebakmaz, O., Akkaya, H., Kaya, E. G., Akpek, M., Kalay, N., Dikilitas, M., Yarlioglues, M., Karaca, H., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.023 · Cited by 325
Chen, J., Fujii, K., Zhang, L., Roberts, T., & Fu, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141224398 · Cited by 316
Zhu, X., Stergiopoulos, K., & Wu, S. (2009) · Acta Oncologica · doi:10.1080/02841860802314720 · Cited by 312
Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction
Jones, L. W., Eves, N. D., Haykowsky, M., Freedland, S. J., & Mackey, J. R. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70031-2 · Cited by 309
Anthracyclines Induce Calpain-dependent Titin Proteolysis and Necrosis in Cardiomyocytes
Lim, C. C., Zuppinger, C., Guo, X., Kuster, G. M., Helmes, M., Eppenberger, H. M., Suter, T. M., Liao, R., & Sawyer, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308033200 · Cited by 304
Carvedilol Decreases Elevated Oxidative Stress in Human Failing Myocardium
Nakamura, K., Kusano, K., Nakamura, Y., Kakishita, M., Ohta, K., Nagase, S., Yamamoto, M., Miyaji, K., Saito, H., Morita, H., et al. (2002) · Circulation · doi:10.1161/01.cir.0000018605.14470.dd · Cited by 291
Metformin Prevents Progression of Heart Failure in Dogs: Role of AMP-Activated Protein Kinase
Sasaki, H., Asanuma, H., Fujita, M., Takahama, H., Wakeno, M., Ito, S., Ogai, A., Asakura, M., Kim, J., Minamino, T., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.798561 · Cited by 289
Statins and cancer: A systematic review and meta-analysis
Kuoppala, J., Lamminpää, A., & Pukkala, E. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.025 · Cited by 285
Finck, B. N., & Kelly, D. P. (2007) · Circulation · doi:10.1161/circulationaha.107.670588 · Cited by 282
β-Blockers alprenolol and carvedilol stimulate β-arrestin-mediated EGFR transactivation
Kim, I.-M., Tilley, D. G., Chen, J., Salazar, N. C., Whalen, E. J., Violin, J. D., & Rockman, H. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804745105 · Cited by 276
Liu, X., Gu, X., Li, Z., Li, X., Li, H., Chang, J., Chen, P., Jin, J., Xi, B., Chen, D., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.057 · Cited by 274
De Angelis, A., Piegari, E., Cappetta, D., Marino, L., Filippelli, A., Berrino, L., Ferreira-Martins, J., Zheng, H., Hosoda, T., Rota, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.895771 · Cited by 268
Efficiency of Atorvastatin in the Protection of Anthracycline-Induced Cardiomyopathy
Acar, Z., Kale, A., Turgut, M., Demircan, S., Durna, K., Demir, S., Meriç, M., & Ağaç, M. T. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.05.025 · Cited by 255
Eichhorn, E. J., Bedotto, J. B., Malloy, C. R., Hatfield, B. A., Deitchman, D., Brown, M., Willard, J. E., & Grayburn, P. A. (1990) · Circulation · doi:10.1161/01.cir.82.2.473 · Cited by 243
Kerkela, R., Woulfe, K. C., Durand, J., Vagnozzi, R., Kramer, D., Chu, T. F., Beahm, C., Chen, M. H., & Force, T. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00090.x · Cited by 242
Selectivity and therapeutic inhibition of kinases: to be or not to be?
Ghoreschi, K., Laurence, A., & O'Shea, J. J. (2009) · Nature Immunology · doi:10.1038/ni.1701 · Cited by 241
Fukazawa, R. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.09.012 · Cited by 238
Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate
Telli, M. L., Witteles, R. M., Fisher, G. A., & Srinivas, S. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn168 · Cited by 237
Molecular Basis of Anthracycline-Induced Cardiotoxicity and Its Prevention
Horenstein, M. S., Vander Heide, R. S., & L'Ecuyer, T. J. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3043 · Cited by 228
Broeders, M. A. W., Doevendans, P. A., Bekkers, B. C. A. M., Bronsaer, R., van Gorsel, E., Heemskerk, J. W. M., Egbrink, M. G. A. O., van Breda, E., Reneman, R. S., & van der Zee, R. (2000) · Circulation · doi:10.1161/01.cir.102.6.677 · Cited by 219
Coronary Microvascular Pericytes Are the Cellular Target of Sunitinib Malate–Induced Cardiotoxicity
Chintalgattu, V., Rees, M. L., Culver, J. C., Goel, A., Jiffar, T., Zhang, J., Dunner, K., Pati, S., Bankson, J. A., Pasqualini, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005066 · Cited by 214
Dessy, C., Saliez, J., Ghisdal, P., Daneau, G., Lobysheva, I. I., Frérart, F., Belge, C., Jnaoui, K., Noirhomme, P., Feron, O., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.532960 · Cited by 210
Horie, T., Ono, K., Nishi, H., Nagao, K., Kinoshita, M., Watanabe, S., Kuwabara, Y., Nakashima, Y., Takanabe-Mori, R., Nishi, E., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq148 · Cited by 208
Pretreatment with Statin Attenuates the Cardiotoxicity of Doxorubicin in Mice
Riad, A., Bien, S., Westermann, D., Becher, P. M., Loya, K., Landmesser, U., Kroemer, H. K., Schultheiss, H. P., & Tschöpe, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3076 · Cited by 205
Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis
Yamaguchi, O., Watanabe, T., Nishida, K., Kashiwase, K., Higuchi, Y., Takeda, T., Hikoso, S., Hirotani, S., Asahi, M., Taniike, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420317 · Cited by 204
Huang, C., Zhang, X., Ramil, J. M., Rikka, S., Kim, L., Lee, Y., Gude, N. A., Thistlethwaite, P. A., Sussman, M. A., Gottlieb, R. A., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.902221 · Cited by 203
Zentilin, L., Puligadda, U., Lionetti, V., Zacchigna, S., Collesi, C., Pattarini, L., Ruozi, G., Camporesi, S., Sinagra, G., Pepe, M., et al. (2010) · The FASEB Journal · doi:10.1096/fj.09-143180 · Cited by 200
Role of Neuregulin-1/ErbB2 Signaling in Endothelium-Cardiomyocyte Cross-talk
Lemmens, K., Segers, V. F. M., Demolder, M., & De Keulenaer, G. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600399200 · Cited by 192
Nitric oxide mediated venodilator effects of nebivolol.
Bowman, A., Chen, C., & Ford, G. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04342.x · Cited by 190
Chintalgattu, V., Ai, D., Langley, R. R., Zhang, J., Bankson, J. A., Shih, T. L., Reddy, A. K., Coombes, K. R., Daher, I. N., Pati, S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39434 · Cited by 188
Scott, J. M., Khakoo, A., Mackey, J. R., Haykowsky, M. J., Douglas, P. S., & Jones, L. W. (2011) · Circulation · doi:10.1161/circulationaha.111.021774 · Cited by 188
Effects by doxorubicin on the myocardium are mediated by oxygen free radicals
Xu, M. F., Tang, P. L., Qian, Z. M., & Ashraf, M. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)00990-5 · Cited by 185
Richards, C. J., Je, Y., Schutz, F. A. B., Heng, D. Y. C., Dallabrida, S. M., Moslehi, J. J., & Choueiri, T. K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4309 · Cited by 180
Harris, I. S., Zhang, S., Treskov, I., Kovacs, A., Weinheimer, C., & Muslin, A. J. (2004) · Circulation · doi:10.1161/01.cir.0000138190.50127.6a · Cited by 177
Fuller, S. J., Sivarajah, K., & Sugden, P. H. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.02.278 · Cited by 175
Carvedilol Protects against Doxorubicin-Induced Mitochondrial Cardiomyopathy
Santos, D. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9532 · Cited by 174
Emerging Paradigms in Cardiomyopathies Associated With Cancer Therapies
Ky, B., Vejpongsa, P., Yeh, E. T. H., Force, T., & Moslehi, J. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.300218 · Cited by 170
Self-citationMetformin improves cardiac function in a nondiabetic rat model of post-MI heart failure
Yin, M., van der Horst, I. C. C., van Melle, J. P., Qian, C., van Gilst, W. H., Silljé, H. H. W., & de Boer, R. A. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00054.2011 · Cited by 170
Sassano, A., & Platanias, L. C. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.036 · Cited by 168
Moslehi, J., Minamishima, Y. A., Shi, J., Neuberg, D., Charytan, D. M., Padera, R. F., Signoretti, S., Liao, R., & Kaelin, W. G. (2010) · Circulation · doi:10.1161/circulationaha.109.922427 · Cited by 167
Cardiotoxic and Cardioprotective Features of Chronic β-Adrenergic Signaling
Zhang, X., Szeto, C. W., Gao, E., Tang, M., Jin, J., Fu, Q., Makarewich, C. A., Ai, X., Li, Y., Tang, A., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.273896 · Cited by 146
Rohrbach, S., Yan, X., Weinberg, E. O., Hasan, F., Bartúnek, J., Marchionni, M. A., & Lorell, B. H. (1999) · Circulation · doi:10.1161/01.cir.100.4.407 · Cited by 145
NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70S6K, and MEK-MAPK-RSK
Baliga, R. R., Pimental, D. R., Zhao, Y., Simmons, W. W., Marchionni, M. A., Sawyer, D. B., & Kelly, R. A. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.277.5.h2026 · Cited by 144
Adjuvant Trastuzumab Induces Ventricular Remodeling Despite Aerobic Exercise Training
Haykowsky, M. J., Mackey, J. R., Thompson, R. B., Jones, L. W., & Paterson, D. I. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0628 · Cited by 141
Ma, J., Wang, Y., Zheng, D., Meng, W., Xu, H., & Peng, T. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs309 · Cited by 132
Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model
Cittadini, A., Napoli, R., Monti, M. G., Rea, D., Longobardi, S., Netti, P. A., Walser, M., Samà, M., Aimaretti, G., Isgaard, J., et al. (2012) · Diabetes · doi:10.2337/db11-1132 · Cited by 130
Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure
Liu, F.-F., Stone, J. R., Schuldt, A. J. T., Okoshi, K., Okoshi, M. P., Nakayama, M., Ho, K. K. L., Manning, W. J., Marchionni, M. A., Lorell, B. H., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00268.2005 · Cited by 128
Hasinoff, B. B., Patel, D., & O’Hara, K. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050104 · Cited by 126
Jones, L. W., Haykowsky, M. J., Peddle‐McIntyre, C. J., Joy, A. A., Pituskin, E., Tkachuk, L., Courneya, K. S., Slamon, D. J., & Mackey, J. R. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0870 · Cited by 120
Management of Antiangiogenic Therapy-Induced Hypertension
de Jesús-González, N., Robinson, E., Moslehi, J. J., & Humphreys, B. D. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.196774 · Cited by 120
Rohrbach, S., Niemann, B., Silber, R.-E., & Holtz, J. (2005) · Basic Research in Cardiology · doi:10.1007/s00395-005-0514-4 · Cited by 117
Ayach, B., Yoshimitsu, M., Dawood, F., Sun, M., Arab, S., Chen, M., Higuchi, K., Siatskas, C., Lee, P. C., Lim, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510997103 · Cited by 115
Cardiovascular Disease: Cause of Morbidity and Mortality in Adult Survivors of Childhood Cancers
Chen, M. H., Colan, S. D., & Diller, L. (2011) · Circulation Research · doi:10.1161/circresaha.110.224519 · Cited by 113
Cardiotoxicity of the new cancer therapeutics – mechanisms of, and approaches to, the problem
Force, T. L., & Kerkelä, R. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.05.011 · Cited by 108
Sanbe, A., Tanonaka, K., Kobayashi, R., & Takeo, S. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(95)91551-6 · Cited by 108
Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity
Huelsenbeck, J., Henninger, C., Schad, A., Lackner, K. J., Kaina, B., & Fritz, G. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.65 · Cited by 98
Strategies to Prevent and Treat Cardiovascular Risk in Cancer Patients
Cardinale, D. M., Bacchiani, G., Beggiato, M., Colombo, A., & Cipolla, C. M. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.01.008 · Cited by 97
Pepe, M., Mamdani, M., Zentilin, L., Csiszar, A., Qanud, K., Zacchigna, S., Ungvari, Z., Puligadda, U., Moimas, S., Xu, X., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.220855 · Cited by 93
Damrot, J., Nübel, T., Epe, B., Roos, W. P., Kaina, B., & Fritz, G. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706953 · Cited by 90
Rac1 Protein Signaling Is Required for DNA Damage Response Stimulated by Topoisomerase II Poisons
Huelsenbeck, S. C., Schorr, A., Roos, W. P., Huelsenbeck, J., Henninger, C., Kaina, B., & Fritz, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.377903 · Cited by 90
Cheng, H., Kari, G., Dicker, A. P., Rodeck, U., Koch, W. J., & Force, T. L. (2011) · Circulation Research · doi:10.1161/circresaha.111.255695 · Cited by 90
Jay, S. M., Murthy, A. C., Hawkins, J. F., Wortzel, J. R., Steinhauser, M. L., Alvarez, L. M., Gannon, J., MacRae, C. A., Griffith, L. G., & Lee, R. T. (2013) · Circulation · doi:10.1161/circulationaha.113.002203 · Cited by 89
Pituskin, E., Haykowsky, M. J., Mackey, J. R., Thompson, R. B., Ezekowitz, J. A., Koshman, S. L., Oudit, G. Y., Chow, K., Pagano, J. J., & Paterson, D. I. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-318 · Cited by 89
Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins
Bian, Y., Sun, M., Silver, M., Ho, K. K. L., Marchionni, M. A., Caggiano, A. O., Stone, J. R., Amende, I., Hampton, T., Morgan, J. P., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01010.2008 · Cited by 82
Heat Shock Protein 90 and ErbB2 in the Cardiac Response to Doxorubicin Injury
Gabrielson, K. L., Bedja, D., Pin, S., Tsao, A. L., Gama, L., Yuan, B., & Muratore, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3721 · Cited by 81
The Emerging Issue of Cardiac Dysfunction Induced by Antineoplastic Angiogenesis Inhibitors
Tocchetti, C. G., Gallucci, G., Coppola, C., Piscopo, G., Cipresso, C., Maurea, C., Giudice, A., Iaffaioli, R. V., Arra, C., & Maurea, N. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft008 · Cited by 77
The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
Erickson, C. E., Gul, R., Blessing, C. P., Nguyen, J. H., Liu, T., Pulakat, L., Bastepe, M., Jackson, E. K., & Andresen, B. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071980 · Cited by 76
Tokudome, T., Mizushige, K., Noma, T., Manabe, K., Murakami, K., Tsuji, T., Nozaki, S., Tomohiro, A., & Matsuo, H. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200009000-00012 · Cited by 66
Vaynblat, M., Shah, H. R., Bhaskaran, D., Ramdev, G., Davis, W. J., Cunningham, J. N., & Chiavarelli, M. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00091-0 · Cited by 64
Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart
Uray, I. P., Connelly, J. H., Thomázy, V. A., Shipley, G. L., Vaughn, W. K., Frazier, O. H., Taegtmeyer, H., & Davies, P. J. (2002) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)00390-x · Cited by 62
Asanuma, H., Minamino, T., Sanada, S., Takashima, S., Ogita, H., Ogai, A., Asakura, M., Liao, Y., Asano, Y., Shintani, Y., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130917.12959.04 · Cited by 54
Boucek, R. J., Steele, A., Miracle, A. L., & Atkinson, J. (2003) · Cardiovascular Toxicology · doi:10.1385/ct:3:4:319 · Cited by 53
Maurea, N., Coppola, C., Ragone, G., Frasci, G., Bonelli, A., Romano, C., & Iaffaioli, R. V. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328336b4c1 · Cited by 49
Scott, J. M., Gilchrist, S. C., Mackey, J. R., Douglas, P. S., Haykowsky, M. J., & Jones, L. W. (2013) · The Oncologist · doi:10.1634/theoncologist.2012-0226 · Cited by 49
Treatment of arterial hypertension (AHT) associated with angiogenesis inhibitors
Dirix, L. Y., Maes, H., & Sweldens, C. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm205 · Cited by 45
Scott, J. M., Koelwyn, G. J., Hornsby, W., Khouri, M. G., Peppercorn, J. M., Douglas, P. S., & Jones, L. W. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.01.001 · Cited by 41
Wartlick, F., Bopp, A., Henninger, C., & Fritz, G. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.08.016 · Cited by 35
LeBrasseur, N. K., Mizer, K., Parkington, J. D., et al. (2005) · European Journal of Applied Physiology · doi:10.1007/s00421-005-1333-4 · Cited by 23
Verkhivker, G. M. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm277 · Cited by 19
Cited by
Anthracycline Chemotherapy and Cardiotoxicity
McGowan, J. V., Chung, R., Maulik, A., Piotrowska, I., Walker, J. M., & Yellon, D. M. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6711-0 · Cited by 956
Bozkurt, B., Colvin, M., Cook, J., Cooper, L. T., Deswal, A., Fonarow, G. C., Francis, G. S., Lenihan, D., Lewis, E. F., McNamara, D. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000455 · Cited by 891
Self-citationMehta, L. S., Watson, K. E., Barac, A., Beckie, T. M., Bittner, V., Cruz-Flores, S., Dent, S., Kondapalli, L., Ky, B., Okwuosa, T., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000556 · Cited by 848
Self-citationBairey Merz, C. N., Pepine, C. J., Walsh, M. N., Fleg, J. L., Camici, P. G., Chilian, W. M., Clayton, J. A., Cooper, L. S., Crea, F., Di Carli, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024534 · Cited by 748
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Curigliano, G., Cardinale, D., Dent, S., Criscitiello, C., Aseyev, O., Lenihan, D., & Cipolla, C. M. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21341 · Cited by 723
Self-citation
Metadata
- Authors
- Hahn, V. S., Lenihan, D. J., & Ky, B.
- Venue
- Journal of the American Heart Association
- Published
- 2014-03-24
- Volume
- 3
- Issue
- 2
- Pages
- e000665-e000665
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W2153362990
- Cited by
- 264
- References
- 131
- FWCI
- 17.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.